首页> 外国专利> STEPPED CARDIOVERSION SYSTEM FOR AN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR

STEPPED CARDIOVERSION SYSTEM FOR AN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR

机译:用于可植入式心脏复律除颤器的分级心脏复律系统

摘要

A method and apparatus for treating ventricular tachycardia arrhythmias using an ICD system, delivers a series of stepped cardioversion pulses (120, 122, 124, 126) that include at least a first (120) and second (122) cardioversion countershock of low energy values that are less than about 5 joules. The energy values of each cardioversion countershock increase in stepped progressions in each of the subsequent cardioversion countershocks (124, 126). The use of a series of stepped cardioversion pulses (120, 122, 124, 126) minimizes the possibility of 'overstimulating' heart cells in any reentrant loops that are causing the ventricular tachycardia. The leading edge of the series of stepped cardioversion pulses (120, 122, 124, 126) is sufficient to just stimulate any heart cells that are in phase 4, but is not strong enough to stimulate heart cells that are in phase 3. Thus, if a reentrant loop is within the reaches of the leading edge of a pulse, that reentrant loop is converted without the possibility of inducing fibrillation.
机译:一种使用ICD系统治疗室性心动过速心律失常的方法和装置,传递一系列阶梯式心脏复律脉冲(120、122、124、126),该脉冲至少包括低能量值的第一(120)和第二(122)心脏复律反电击小于约5焦耳。每个电复律反击的能量值在随后的每个电复律反击(124、126)中以阶梯式递增。一系列步进式心脏复律脉冲(120、122、124、126)的使用将“过度刺激”心脏细胞的任何折返环路中引起心室心动过速的可能性降至最低。系列步进式心脏复律脉冲(120、122、124、126)的前沿足以刺激任何处于阶段4的心脏细胞,但强度不足以刺激处于阶段3的心脏细胞。因此,如果折返环在脉冲前沿范围之内,则该折返环将被转换而不会引起原纤化。

著录项

  • 公开/公告号EP0738171A4

    专利类型

  • 公开/公告日1998-02-25

    原文格式PDF

  • 申请/专利权人 ANGEION CORPORATION;

    申请/专利号EP19950937554

  • 发明设计人 KROLL MARK W.;

    申请日1995-10-10

  • 分类号A61N1/36;A61N1/39;

  • 国家 EP

  • 入库时间 2022-08-22 02:50:13

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号